Earnings

Recap: Aeglea BioTherapeutics Q3 Earnings

Aeglea BioTherapeutics (NASDAQ:AGLE) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

byBenzinga Insights

November 3, 2022

1 minute read

Aeglea BioTherapeutics (NASDAQ:AGLE) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Aeglea BioTherapeutics beat estimated earnings by 17.39%, reporting an EPS of $-0.19 versus an estimate of $-0.23.

Revenue was down $1.23 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 1.23% increase in the share price the next day.

To track all earnings releases for Aeglea BioTherapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Earnings

Sotera Health Earnings Preview

By Benzinga Insights

February 28, 1:05 PM

Sotera Health (NASDAQ:SHC) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts estimate that Sotera Health will report an earnings per share (EPS) of $0.22.

SHC

What’s Going On With Home Depot Stock Today?

By Adam Eckert

August 16, 10:51 AM

Home Depot Inc (NYSE: HD) shares are trading higher Tuesday after the company reported better-than-expected financial results. The stock initially traded lower on the release, but has since staged a reversal.

Femasys Q1 EPS $(0.24) Up From $(1.84) YoY, Sales $321.40K Down From $329.77K YoY

By Benzinga Newsdesk

May 11, 4:53 PM

Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.24) per share. This is a 86.96 percent increase over losses of $(1.84) per share from the same period last year. The company reported $321.40 thousand in sales this

FEMY

Earnings

Genocea Biosciences Earnings Preview

By Benzinga Insights

March 9, 11:31 AM

Genocea Biosciences (NASDAQ:GNCA) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts estimate that Genocea Biosciences will report an earnings per share (EPS) of $-0.20.

GNCA